Hyperliquid Strategies Inc（PURR）股票分析

$9.070

-0.676 (-7.45%)收盘时

Loading chart…

最高: 9.730
开盘: 9.610
成交量加权均价: 9.26
成交量: 11.77M
市值: —
最低: 8.980
成交额: 108.98M
企业价值/息税折旧摊销前利润（TTM）: 0.37

Hyperliquid Strategies Inc is a digital asset treasury company. The Company is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.

AI 分析 of Hyperliquid Strategies Inc (PURR)

买入

Hyperliquid Strategies Inc (PURR) is a good buy right now due to its significant growth potential and strong market position. The current price is $11.11, and analysts have set a price target of $18, which represents a potential upside of 63%. Additionally, the company has shown impressive revenue growth, with Q4 2026 revenue reaching $6.33 million, and a gross margin of 100% in the last three quarters, indicating strong profitability. However, the main risk is the ongoing investigation into insider trading, which could impact market sentiment and investor confidence.